Blog
By Andrew Kusmierczyk, Scientist, CMC, Cardinal Health Regulatory Sciences Publication plans. Journal articles. Conference abstracts. Investigator brochures. INDs. NDAs. BLAs. MSL slide decks. Scientific platforms. Educational materials for HCPs. Talk tracks. Visual Aids. Pa … Read More »
Nearly 80% of clinical trials fail to meet their activation timelines. But why does the start-up process fail us this often? This question can be answered by implementing a Feasibility Maturity Model with six critical variables. Understand the 6 key variables: bit.ly/2IORt0c
The aim of this article is to discuss the current use of real-world data and evidence in health technology assessment (HTA) and payer appraisals, its potential role in lifecycle management, and how the early dialogue provided by Integrated Scientific Advice (ISA) engagement … Read More »
This month’s SpeakOut sets its sites on real-world data as a driver of outcomes. Joe Jackson, SVP Operations at EngagedMedia, takes a look at how mobile devices and patient-generated data influence the overall care plan, and how pharma marketers can utilize the data for stra … Read More »
October 21-22, 2019 in Washington, D.C. The Rare Summit affords an unprecedented opportunity to hear from the experts, including the heads of the three FDA medical centers, and join conversations of the pressing issues facing the rare disease community, including addressing … Read More »
Register today for our day-long #patientadvocacy forum on Oct 23 in Washington, DC! We’ll bring together Patient Advocacy Groups, patients, and drug developers to discuss ways to make real change that increase the value to patients in clinical research. bit.ly/2m2VsOb
By: Vincent Marino, Director of Strategic Partnerships, SHYFT Analytics The last decade has seen an explosion in the volume of patient-level data available to companies marketing specialty therapies. Drug manufacturers and industry business partners have responded by buildin … Read More »
Given the rapid changes in #clinicalresearch, it can be challenging for sites to thrive & event grow. In this conference, we will focus on how to differentiate your site for success. Join WCG on Oct 7 in Philadelphia, PA to learn more: bit.ly/2kuisoZ
There’s an entirely new way to listen to patients, enabling researchers to better understand the patient experience by capturing authentic stories and translating sound science into actionable insights. This structured methodology combined with sociolinguistic analysis and A … Read More »
In April 2019, members of Evidera’s Policy Trends team had the opportunity to speak with scientific staff members from the Canadian Agency for Drugs and Technologies in Health (CADTH) to discuss new opportunities available through CADTH’s scientific advice services. Read the … Read More »
This post contains excerpts from the June 2019 cover article in PharmaVOICE Magazine, written by Robin Robinson. Cognizant has been using AR technology at clinical congresses for several years, says Bryan Hill, chief technology officer, life sciences, Cognizant. One particul … Read More »
In the June Speak OUT feature in PharmaVOICE Magazine, Larissa Comis of Cognizant describes how the Cognizant Shared Investigator Platform is a disruptive innovation that can help companies achieve positive outcomes. Best Practices for Adopting the Shared Investigator Platfo … Read More »
CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health(signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signan … Read More »
In a June 6 webinar, industry experts from Inteliquet will demonstrate specifically how machine learning can augment and assist human intelligence to perform better patient forecasting. By extracting pertinent EMR information, including physicians’ notes, reading binary dat … Read More »
If there are lingering doubts about the viability or market potential of digital therapeutics (DTx), recent moves by the U.S. Food & Drug Administration should lay them to rest. In December 2018, Pear Therapeutics and its partner, Novartis’ Sandoz unit, received FDA clea … Read More »
Listening and interpreting the patient’s views throughout their journey of care is an important and elusive goal. inVibe Labs has developed a lexicon guide for disease states, that helps shed some light on what a patient is saying about their care as they progress through th … Read More »
The importance of a good agency/client relationship cannot be overstated. In the May issue of PharmaVOICE magazine, Allison Davis of closerlook provides insights and advice into making this crucial relationship work. Read article http://bit.ly/PV-May2019-56 Here are some of … Read More »
Evidera has published an informative article to provide some baseline knowledge about the “why, who, what, and how” when it comes to clinical outcome assessments for rare disease trials. Read the article: http://bit.ly/Evidera05202019 Key points in the paper: Patient inclus … Read More »
An upcoming webinar explores Service Design Methods as a way of accelerating business objectives and improving the patient experience. Industry experts will share their knowledge and experiences on this topic, and will field questions from the audience after their presentati … Read More »
In a June 6 webinar, industry experts from Inteliquet will demonstrate specifically how machine learning can augment and assist human intelligence to perform better patient forecasting. By extracting pertinent EMR information, including physicians’ notes, reading binary dat … Read More »
